APPLICATION
ANDA208580
TYPE
ANDA
ORIGINAL APPROVAL
2018-05-04
LATEST ACTION
2025-07-09
ROUTE
INTRAVENOUS
DOSAGE FORM
INJECTABLE
MARKETING STATUS
Discontinued
Products
PANTOPRAZOLE SODIUMDiscontinued
PANTOPRAZOLE SODIUM EQ 40MG BASE/VIAL · INJECTABLE · INTRAVENOUS
Approval history
2025-07-09Labeling · Supplement 6 · standardAP
2025-07-09Labeling · Supplement 4 · standardAP
2025-07-09Labeling · Supplement 7 · standardAP
2025-07-09Labeling · Supplement 5 · standardAP
2021-04-08Labeling · Supplement 3 · standardAP
2021-04-08Labeling · Supplement 1 · standardAP
2021-04-08Labeling · Supplement 2 · standardAP
2018-05-04UNKNOWN · Original · standardAP
Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.
Weekly Briefing
Read a past issue →Get the Weekly GxP Briefing
Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.